Skip to main content

Table 4 Association between parity and the prevalence of metabolic disorders

From: The association between parity and metabolic syndrome and its components in normal-weight postmenopausal women in China

Parity

Crude

Model 1

Model 2

Model 3

OR(95%CI)

P-value

OR (95%CI)

P-value

OR (95%CI)

P-value

OR (95%CI)

P-value

Abdominal obesity

 1

Refrence

 

Refrence

 

Refrence

 

Refrence

 

 2

1.58 (1.11, 2.27)

0.012

1.68 (1.14, 2.46)

0.009

1.45 (0.93, 2.24)

0.099

1.33 (0.83, 2.14)

0.234

 3

2.57 (1.71, 3.87)

< 0.001

2.83 (1.76, 4.54)

< 0.001

2.54 (1.46, 4.40)

0.001

2.06 (1.13, 3.77)

0.019

 ≥4

4.46 (2.61, 7.61)

< 0.001

4.99 (2.72, 9.17)

< 0.001

4.25 (2.11, 8.56)

< 0.001

3.08 (1.42, 6.66)

0.004

P for trend

1.63 (1.40, 1.90)

< 0.001

1.70 (1.41, 2.05)

< 0.001

1.63 (1.31, 2.02)

< 0.001

1.46 (1.15, 1.86)

0.002

High FPG

 1

Refrence

 

Refrence

   

Refrence

 

 2

1.32 (0.90, 1.92)

0.153

1.20 (0.80, 1.79)

0.385

1.15 (0.75, 1.76)

0.516

1.18 (0.77, 1.81)

0.460

 3

1.54 (1.01, 2.33)

0.043

1.31 (0.81, 2.11)

0.276

1.22 (0.72, 2.07)

0.450

1.27 (0.75, 2.16)

0.375

 ≥4

1.38 (0.83, 2.28)

0.210

1.14 (0.64, 2.03)

0.664

1.04 (0.55, 1.97)

0.911

1.10 (0.57, 2.11)

0.777

P for trend

1.14 (0.98, 1.33)

0.081

1.06 (0.89, 1.27)

0.531

1.03 (0.84, 1.25)

0.806

1.05 (0.85, 1.28)

0.672

High Bp

 1

Refrence

 

Refrence

   

Refrence

 

 2

1.46 (1.02, 2.08)

0.040

1.16 (0.79, 1.70)

0.460

1.01 (0.67, 1.52)

0.966

1.02 (0.67, 1.53)

0.942

 3

2.13 (1.42, 3.18)

< 0.001

1.45 (0.91, 2.30)

0.117

1.16 (0.70, 1.93)

0.559

1.20 (0.72, 2.00)

0.489

 ≥4

2.60 (1.58, 4.26)

< 0.001

1.65 (0.94, 2.90)

0.084

1.27 (0.68,2.37)

0.461

1.31 (0.69, 2.49)

0.401

P for trend

1.40 (1.21, 1.62)

< 0.001

1.19 (1.00, 1.42)

0.049

1.09 (0.89, 1.33)

0.395

1.10 (0.90, 1.35)

0.332

Elevated TG

 1

Refrence

 

Refrence

   

Refrence

 

 2

1.49 (1.04, 2.14)

0.031

1.06 (0.72, 1.57)

0.755

1.03 (0.68, 1.57)

0.873

1.00 (0.66, 1.52)

0.990

 3

1.48 (0.99, 2.22)

0.054

0.84 (0.52, 1.34)

0.463

0.88 (0.53, 1.47)

0.619

0.83 (0.49, 1.40)

0.482

 ≥4

1.34 (0.82, 2.17)

0.242

0.67 (0.38, 1.19)

0.175

0.71 (0.38, 1.34)

0.294

0.65 (0.34, 1.24)

0.191

P for trend

1.12 (0.97, 1.29)

0.134

0.87(0.73, 1.04)

0.126

0.89 (0.73, 1.09)

0.264

0.87 (0.71, 1.06)

0.169

low HDL-C

 1

Refrence

 

Refrence

   

Refrence

 

 2

1.64 (1.08, 2.49)

0.019

1.48 (0.95, 2.30)

0.083

1.41 (0.88, 2.26)

0.156

1.37 (0.85, 2.21)

0.190

 3

1.48 (0.93, 2.35)

0.096

1.24 (0.73, 2.11)

0.422

1.13 (0.63, 2.01)

0.690

1.10 (0.61, 1.97)

0.756

 ≥4

1.47 (0.85, 2.56)

0.168

1.20 (0.64, 2.25)

0.577

1.01 (0.50, 2.05)

0.978

0.96 (0.47, 1.97)

0.910

P for trend

1.12 (0.96, 1.32)

0.152

1.03 (0.85, 1.25)

0.745

0.98(0.78, 1.22)

0.831

0.96 (0.77, 1.20)

0.741

  1. Model 1: adjusted for age;
  2. Model2: adjusted for model 1 + BMI, smoking, drinking, exercise, education first-degree relatives of patients with diabetes, pregnancy losses, age at menarche, duration of reproductive years, exercise;
  3. Model3: adjust for model 2 +hip circumference;
  4. Abbreviations: CI Confidence interval, OR Odds ratio, FPG Fasting plasma glucose, TG Triglyceride, HDL-C High density lipoprotein cholesterol, Bp Blood pressure
Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us